STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
148
13F, latest reported quarter
What the filings say about HG
Insiders, 180 days
-$6.0M net sold
4 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$3.8M
3 notices
Hamilton Insurance insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Hamilton Insurance Group, Ltd. insiders sold a net $6.0M of stock across 53 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Sep 10, 2026.
The trade is 14.6% of the 194,959 shares held after it.
1 other insider sold within 30 days.
148 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Underwriting Officer Duffin Timothy James sold about $988.6K of HG on Sep 11, 2026; 1 other insider sold within 30 days and 148 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 12.8% of the 223,459 shares held after it.
1 other insider sold within 30 days.
148 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Underwriting Officer Duffin Timothy James sold about $984.2K of HG on Sep 10, 2026; 1 other insider sold within 30 days and 148 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 18, 2026.
The trade is 12.5% of the 400,000 shares held after it.
1 other insider sold within 30 days.
148 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director BROWN DAVID A sold about $1.8M of HG on Sep 3, 2026, the largest insider sale at the company since 2023; 1 other insider sold within 30 days and 148 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on May 15, 2026.
The trade is 8.3% of the 450,000 shares held after it.
2 other insiders sold within 30 days.
148 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director BROWN DAVID A sold about $1.2M of HG on May 18, 2026, the largest insider sale at the company since 2023; 2 other insiders sold within 30 days and 148 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 2.6% of the 487,300 shares held after it.
2 other insiders sold within 30 days.
148 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director BROWN DAVID A sold about $404.1K of HG on May 15, 2026; 2 other insiders sold within 30 days and 148 funds added in the latest 13F quarter.
53 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
HG planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
TIMOTHY JAMES DUFFIN
Filed 2026-09-11
$988.6K
TIMOTHY JAMES DUFFIN
Filed 2026-09-10
$984.2K
LEYTON LTD
Filed 2026-09-03
$1.8M
HG mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Knights of Columbus Small Cap Equity Fund
$3.0M position · as of 2026-07-31
1.4%
Nuveen Small Cap Value Fund
$3.4M position · as of 2026-07-31
1.2%
Applied Finance IVS US SMID ETF
$177.4K position · as of 2026-06-30
0.7%
HUSSMAN STRATEGIC MARKET CYCLE FUND
$2.0M position · as of 2026-06-30
0.6%
Small Cap Value Fund
$15.8M position · as of 2026-06-30
0.5%
YORKTOWN GROWTH FUND
$607.7K position · as of 2026-07-31
0.5%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Giuseppina (Pina) Albo
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$9.0M
$24.8M
$2.9M
+86%
+53%
2024
$8.6M
$17.2M
$2.8M
+27%
+39%
2023
$12.8M
$15.6M
$2.9M
-0%
+2%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $6.0M sold by insiders over 180 days, 148 funds added last quarter, $3.8M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt HG
FY Dec 2025
5.63x
FY Dec 2024
5.06x
FY Dec 2023
1.89x
FY Dec 2022
n/a
FY Nov 2021
n/a
Jun 2026
5.44x
Mar 2026
6.06x
Dec 2025
5.63x
Sep 2025
5.56x
Jun 2025
4.66x
Mar 2025
4.24x
Dec 2024
5.06x
Sep 2024
3.41x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+31.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity HG
FY Dec 2025
+32.6%
FY Dec 2024
+28.0%
FY Dec 2023
+15.1%
FY Dec 2022
n/a
FY Nov 2021
n/a
Jun 2026
+31.9%
Mar 2026
+34.2%
Dec 2025
+32.6%
Sep 2025
+28.1%
Jun 2025
+24.4%
Mar 2025
+22.4%
Dec 2024
+28.0%
Sep 2024
+32.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+9.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets HG
FY Dec 2025
+9.7%
FY Dec 2024
+8.5%
FY Dec 2023
+4.5%
FY Dec 2022
n/a
FY Nov 2021
n/a
Jun 2026
+9.0%
Mar 2026
+9.6%
Dec 2025
+9.7%
Sep 2025
+8.2%
Jun 2025
+7.1%
Mar 2025
+6.6%
Dec 2024
+8.5%
Sep 2024
+9.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital HG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Nov 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed HG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Nov 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
6.35x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing HG
FY Dec 2025
5.03x
FY Dec 2024
5.20x
FY Dec 2023
6.15x
FY Dec 2022
n/a
FY Nov 2021
n/a
Jun 2026
5.93x
Mar 2026
4.90x
Dec 2025
5.03x
Sep 2025
5.88x
Jun 2025
5.94x
Mar 2025
6.80x
Dec 2024
5.20x
Sep 2024
4.30x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.8B
market value at close 2026-10-26 on 2026-07-31 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value HG
FY Dec 2025
$888.0M
FY Dec 2024
$375.1M
FY Dec 2023
$193.1M
FY Dec 2022
n/a
FY Nov 2021
n/a
Jun 2026
$1.7B
Mar 2026
$1.3B
Dec 2025
$888.0M
Sep 2025
$821.6M
Jun 2025
$612.9M
Mar 2025
$651.0M
Dec 2024
$375.1M
Sep 2024
$378.8M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield HG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Nov 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.11x
P/E over trailing EPS growth of 57%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing HG
FY Dec 2025
0.10x
FY Dec 2024
0.10x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Nov 2021
n/a
Jun 2026
0.10x
Mar 2026
0.05x
Dec 2025
0.10x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
0.10x
Sep 2024
0.01x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
HG ranks highest on financial health (90th percentile) and profitability (89th), and lowest on insider conviction (17th), among Insurance peers.
Profitability
89
Inputs
Return on equity+31.9% · 90 pct, sector of 116
Return on assets+9.0% · 89 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
90
Inputs
Debt to equity0.05x · 87 pct, sector of 104
Cash flow to debt5.44x · 92 pct, sector of 97
Growth
77
Inputs
Revenue growth, YoY+24.7% · 77 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
17
Inputs
Net Form 4 buying (codes P and S), 180d-$6.0M · 34 pct, sector of 100
Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
50
Inputs
Funds adding, latest quarter148 · 50 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
30
Inputs
Short interest, % of float+3.0% · 59 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+61.0% · 0 pct, sector of 110
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HG filings, in plain words
Are Hamilton Insurance insiders buying or selling HG?
In the 180 days to 2026-10-28, Hamilton Insurance insiders were net sellers, a net $6.0M across purchases and sales reported on Form 4, by 4 sellers.
Are there planned insider sales of HG?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $3.8M of stock; the latest, by TIMOTHY JAMES DUFFIN, was filed 2026-09-11.
Read the full summary
In the 180 days to 2026-10-28, Hamilton Insurance insiders were net sellers of HG, a net $6.0M across purchases and sales reported on Form 4 by 4 sellers. None of the 8 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $3.8M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.